PC-1/PrLZ Confers Resistance to Rapamycin in Prostate Cancer Cells Through Increased 4e-Bp1 Stability

Oncotarget - United States
doi 10.18632/oncotarget.3931
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

The 4e-Bp1/eIF4E Ratio Is a Determinant for Rapamycin Response in Esophageal Cancer Cells

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2015English

HMGB1‑mediated Autophagy Confers Resistance to Gemcitabine in Hormone‑independent Prostate Cancer Cells

Oncology Letters
Cancer ResearchOncology
2017English

PIM2 Regulates Stemness Through Phosphorylation of 4e-Bp1

Science Bulletin
Multidisciplinary
2017English

Rapamycin Inhibits Cell Motility by Suppression of mTOR-mediated S6K1 and 4e-Bp1 Pathways

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Pancreatic Tumours Escape From Translational Control Through 4e-Bp1 Loss

Oncogene
Cancer ResearchGeneticsMolecular Biology
2013English

McL-1 Stabilization Confers Resistance to Taxol in Human Gastric Cancer

Oncotarget
Oncology
2017English

Functional Characterization of a Novel Prostate-Specific Gene PrLZ in Prostate Cancer

2006English

FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

Mp37-13 Accelerated Cell Proliferation and Enhanced Resistance to Docetaxel by Inhibition of 4e-Binding Protein 1 Expression in Human Castration-Resistant Prostate Cancer Pc3 Cells

Journal of Urology
Urology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy